Full Text DK-95-004 SUPPORT OF MINORITIES IN DIABETES, DIGESTIVE AND KIDNEY DISEASE RESEARCH NIH GUIDE, Volume 24, Number 2, January 20, 1995 RFA: DK-95-004 P.T. Keywords: National Institute of Diabetes and Digestive and Kidney Diseases Office of Research on Minority Health Letter of Intent Receipt Date: March 2, 1995 Application Receipt Date: April 19, 1995 PURPOSE The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Office of Research on Minority Health (ORMH) recognizes the need to increase the number of underrepresented minorities committed to scientific careers in research areas served by the Institute. This program is aimed primarily at recently trained M.D. and/or Ph.D. minority investigators. The program will enable the minority applicant to accept a tenure-earning position, gain additional research experience and obtain preliminary data on which to base a subsequent research grant application in an area of diabetes, endocrinology, metabolism, digestive diseases and nutrition, kidney, urology or hematology. HEALTHY PEOPLE 2000 The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2000," a PHS-led national activity for setting priority areas. This RFA, Support of Minorities in Diabetes, Digestive and Kidney Disease Research, is related to the priority area of increasing underrepresented minority health scientists. Potential applicants may obtain a copy of "Healthy People 2000" (Full Report: Stock No. 017-001-00474-0) or "Healthy People 2000" (Summary Report: Stock No. 017-001-00473-1) through the Superintendent of Documents, Government Printing Office, Washington, DC 20402-9325 (telephone 202-783-3238). ELIGIBILITY REQUIREMENTS Applications may be submitted by domestic for-profit and non-profit organizations, public and private, such as universities, colleges, hospitals, laboratories, units of state and local governments, and eligible agencies of the Federal government. The applicant must be African-American, Hispanic, Native American, Pacific Islander, or other ethnic or racial group members underrepresented in biomedical or behavioral research. To apply, one must be a citizen of, or have been lawfully admitted to, the United States for permanent residence. An applicant must have a doctoral degree (M.D., Ph.D., D.O., D.D.S., D.V.M.). He or she should have received at least two years of postgraduate research training in an area of research applicable to research supported in this institute, and have direct access to an expert in the area of the proposed research. Applicants may not hold, nor apply concurrently for any other PHS research project grant at the time of this application. Priority will be given to those applicants who have not previously been a Principal Investigator on a major research grant. Applicants are encouraged to apply for other research project grants (R01, R29) during the course of, or following, this award. MECHANISM OF SUPPORT This RFA will use the National Institutes of Health (NIH) small research grant (R03). Responsibility for the planning, direction, and execution of the proposed project will be that of the applicant. Except as otherwise stated in this RFA, awards will be administered under PHS grants policy as stated in the PHS Grants Policy Statement. This RFA is a one-time solicitation. If the NIDDK determines that there is a sufficient continuing program need, a request for new applications will be announced. The total project period for applications submitted in response to the present RFA may be for one year, but should not exceed two years. Direct costs requested must not exceed $50,000 per year. A grant cannot be renewed. The anticipated award date is September 30, 1995. FUNDS AVAILABLE For FY 1995, $250,000 in total direct costs for year 01 will be committed in each of the three research divisions in the NIDDK. It is anticipated that a total of five awards will be made in each of the three divisions in FY 1995. This level of support depends on the receipt of a sufficient number of applications of high scientific merit. Although this program is provided for in the financial plans of the NIDDK, the award of grants pursuant to this RFA is contingent upon the availability of funds for this purpose. RESEARCH OBJECTIVES The primary purpose of this RFA is to increase the number of underrepresented minority Principal Investigators conducting research in the areas of research supported by the NIDDK. Surveys of research and training programs administered by the NIDDK disclose the need to increase the access to NIDDK support of recently-trained minority scientists who are U.S. citizens or permanent residents. Those who receive several years of training via an individual postdoctoral fellowship or an institutional training grant funded by a National Research Service Award, still require research experience and preliminary data to support an independent research career at this stage of development. An additional period of training may not be feasible for minority individuals with pressing economic burdens. Such individuals may be lost to academic research through a lack of opportunity to obtain an additional one or two years of support essential for establishing a research career. This program was designed to help alleviate some of the noted problems experienced by underrepresented minorities who may wish to pursue a career in academic research. The program will allow the minority investigator to hold a tenure-earning position, gain additional research experience and to obtain preliminary data on which to base a subsequent research grant application. SPECIAL REQUIREMENTS Applicants are required to have available a recognized expert in the area of proposed research for guidance and consultation. It is expected that this expert will assist the applicant in the design and conduct of his/her research. It is not necessary that the expert be at the same institution as the applicant, but he/she should be within a reasonable proximity to be available for guidance and consultation. Following the research plan, the applicant is required to provide a brief summary of his/her long-term career plans and objectives. The application should state how this award would make a difference in and enhance the applicant's development as a scientist. The department chairman/head should provide a brief paragraph indicating his/her plans for the applicant. This official should indicate the extent to which time, space and other necessary support will be provided to the applicant to conduct the proposed investigation(s). A letter from a recognized expert in the area of the proposed research should accompany the application packet. The letter should attest to his/her willingness to provide counsel and advice to the applicant, and an initial plan for ongoing contacts with the applicant. INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS It is the policy of the NIH that women and members of minority groups and their subpopulations must be included in all NIH supported biomedical and behavioral research projects involving human subjects, unless a clear and compelling rationale and justification is provided that inclusion is inappropriate with respect to the health of the subjects or the purpose of the research. This new policy results from the NIH Revitalization Act of 1993 (Section 492B of Public Law 103-43) and supersedes and strengthens the previous policies (Concerning the Inclusion of Women in Study Populations, and Concerning the Inclusion of Minorities in Study Populations), which have been in effect since 1990. The new policy contains some provisions that are substantially different from the 1990 policies. All investigators proposing research involving human subjects should read the "NIH Guidelines For Inclusion of Women and Minorities as Subjects in Clinical Research," which have been published in the Federal Register of March 28, 1994 (FR 59 14508-14513), and reprinted in the NIH Guide for Grants and Contracts, Volume 23, Number 11, March 18, 1994. Investigators also may obtain copies of the policy from the program staff listed under INQUIRIES. Program staff may also provide additional relevant information concerning the policy. LETTER OF INTENT Prospective applicants are asked to submit, by March 2, 1995, a letter of intent that includes a descriptive title of the proposed research, the name, address, and telephone number of the Principal Investigator, his/her institution, the name and address of the expert who has agreed to serve as a consultant and advisor, and the number and title of this RFA. A letter of intent is not required, is not binding and is not considered in the review of applications. It is used by NIDDK staff to initiate planning for the review of applications, to estimate the potential review workload and to avoid possible conflict of interest in the review. The letter of intent is to be sent to: Chief, Review Branch Division of Extramural Activities National Institute of Diabetes and Digestive and Kidney Diseases Natcher Building, Room 6AS 37F 45 Center Drive MSC 6600 Bethesda, MD 20892-6600 Telephone: (301) 594-8886 FAX: (301) 480-3505 APPLICATION PROCEDURES The research grant application form PHS 398 (rev. 9/91) is to be used in applying for these grants. The form is available at most institutional offices of sponsored research and from the Office of Grants Information, Division of Research Grants, National Institutes of Health, 5333 Westbard Avenue, Room 449 Bethesda, MD 20892, telephone 301/710-0267. The RFA label available in the PHS 398 application form must be affixed to the bottom of the face page. Failure to use this label could result in delayed processing of the application such that it may not reach the review committee in time for review. In addition, on line 2a of the face page of the application check the YES box, type the RFA number and the following title: "SUPPORT OF MINORITIES IN DIABETES, DIGESTIVE AND KIDNEY DISEASE RESEARCH." Submit a signed, typewritten original of the application, including the Checklist, and three signed, exact photocopies, in one package to: Division of Research Grants National Institutes of Health Westwood Building, Room 240 Bethesda, MD 20892** Send two additional copies of the application to: Robert Hammond, Ph.D. Division of Extramural Activities National Institute of Diabetes and Digestive and Kidney Diseases Natcher Building, Room 6AS 37F 45 Center Drive MSC 6600 Bethesda, MD 20892-6600 Applications must be received by April 19, 1995. If an application is received after that date, it will be returned to the applicant without review. REVIEW CONSIDERATIONS Applications for the R03 will receive initial technical merit review by an initial review committee appointed by the NIDDK, and second level review by the NIDDK program division to which the application has been assigned. Factors to be considered in the review of applications include: the applicant's previous research training, experience and publications; his/her ability to complete the proposed research plan; the overall scientific merit of the research plan; whether the aims and scope of the research plan can provide definitive data within a one or two year period; the potential of the proposed research to provide the bases for future studies; the institution's willingness to commit facilities and departmental support to the applicant; the applicant's plans and career goals; and the availability of a recognized expert in the area of the proposed research for counsel and advice as attested to by a letter of agreement. AWARD CRITERIA Applications will compete for available funds with all other applications submitted in response to this RFA and recommended by the initial review group. The following will be considered in making funding decisions: o Quality of the proposed project as determined by peer review o Availability of funds o Program balance among research areas of the RFA. INQUIRIES Inquiries concerning this RFA are encouraged. The opportunity to clarify any issues or questions from potential applicants is welcome. Direct inquiries regarding programmatic issues to: Charles H. Rodgers, Ph.D. Division of Kidney, Urologic and Hematologic Diseases National Institute of Diabetes and Digestive and Kidney Diseases Natcher Building, Room 6AS 19J 45 Center Drive MSC 6600 Bethesda, MD 20892-6600 Telephone: (301) 594-7716 Email: chuckr@dvsgate.niddk.nih.gov Judith M. Podskalny, Ph.D. Division of Digestive Diseases and Nutrition National Institute of Diabetes and Digestive and Kidney Diseases Natcher Building, Room 6AN 12E 45 Center Drive MSC 6600 Bethesda, MD 20892-6600 Telephone: (301) 594-8876 Email: judyp@dvsgate.niddk.nih.gov Ronald Margolis, Ph.D. Division of Diabetes, Endocrinology and Metabolism National Institute of Diabetes and Digestive and Kidney Diseases Natcher Building, Room 5AN 12J 45 Center Drive MSC 6600 Bethesda, MD 20892-6600 Telephone: (301) 594-8819 Email: ronm@dvsgate.niddk.nih.gov Direct inquiries regarding fiscal matters to: Ms Nancy C. Dixon Division of Extramural Activities National Institute of Diabetes and Digestive and Kidney Diseases Natcher Building, Room 6AN 44C 45 Center Drive MSC 6600 Bethesda, MD 20892-6600 Telephone: (301) 594-8854 Email: nancyd@dvsgate.niddk.nih.gov Schedule Letter of Intent Receipt Date: March 2, 1995 Application Receipt Date: April 19, 1995 Technical/Scientific Review: June 1995 Review by Divisions/NIDDK: September 1995 Anticipated Award Date: September 30, 1995 AUTHORITY AND REGULATIONS This program is described in the Catalog of Federal Domestic Assistance No. 93.849. Awards are made under authorization of the Public Health Service Act, Title IV, Part A (Public Law 78-410, as amended by Public Law 99-158, 42 USC 241 and 285) and administered under PHS grants policies and Federal Regulations 42 CFR 52 and 45 CFR Part 74. This program is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. The Public Health Service (PHS) strongly encourages all grant recipients to provide a smoke-free workplace and promote the non-use of all tobacco products. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people. .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |